Abstract: A biologically persistent, water-soluble, substantially non-immunogenic, substantially non-antigenic conjugate of superoxide dismutase is prepared by coupling one to five strands of a polyalkylene glycol which is polyethylene glycol or polyethylene-polypropylene glycol copolymer, wherein said polyalkylene glycol has an average molecular weight of about 35,000-1,000,000.
Type:
Grant
Filed:
October 11, 1991
Date of Patent:
February 1, 1994
Assignee:
DDI Pharmaceuticals, Inc.
Inventors:
Mark Saifer, Ralph Somack, L. David Williams
Abstract: A biologically persistent, water-soluble, substantially non-immunogenic, substantially non-antigenic conjugate of superoxide dismutase is prepared by coupling one to five strands of a polyalkylene glycol which is polyethylene glycol or polyethylene-polypropylene glycol copolymer, wherein said polyalkylene glycol has an average molecular weight of about 35,000-1,000,000.
Type:
Grant
Filed:
August 1, 1990
Date of Patent:
January 14, 1992
Assignee:
DDI Pharmaceuticals, Inc.
Inventors:
Mark Saifer, Ralph Somack, L. David Williams
Abstract: A biologically persistent, water-soluble, substantially non-immunogenic, substantially non-antigenic conjugate of superoxide dismutase is prepared by coupling one to five strands of a polyalkylene glycol which is polyethylene glycol or polyethylene-polypropylene glycol copolymer, wherein said polyalkylene glycol has an average molecular weight of about 35,000-1,000,000.
Type:
Grant
Filed:
July 13, 1989
Date of Patent:
April 9, 1991
Assignee:
DDI Pharmaceuticals, Inc.
Inventors:
Mark Saifer, Ralph Somack, L. David Williams